Advanzeon Solutions, Inc. - Quarter Report: 2006 February (Form 10-Q)
Table of Contents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 10-Q
þ | Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
For the quarterly period ended February 28, 2006.
o | Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
For the transition period from to .
Commission
File
Number 1-9927
COMPREHENSIVE CARE CORPORATION
(Exact name of registrant as specified in its charter)
Delaware | 95-2594724 | |
(State or other jurisdiction of incorporation | (IRS Employer Identification No.) | |
or organization) |
204 South Hoover Blvd, Suite 200, Tampa, FL 33609
(Address of principal executive offices and zip code)
(Address of principal executive offices and zip code)
(813) 288-4808
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed
by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.
Yes þ No o
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated
filer, or a non-accelerated filer. See definition of accelerated filer and large accelerated
filer in Rule 12b-2 of the Exchange Act. (Check one):
Large Accelerated Filer o | Accelerated Filer o | Non-Accelerated Filer þ |
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of
the Exchange Act).
Yes o No þ
Indicate the number of shares outstanding of each of the issuers classes of Common Stock, as
of the latest practicable date:
Classes | Outstanding at April 10, 2006 | |
Common Stock, par value $.01 per share | 5,872,374 |
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Index
Page | ||||||||
3 | ||||||||
4 | ||||||||
5 | ||||||||
6-11 | ||||||||
12-19 | ||||||||
19 | ||||||||
19 | ||||||||
19 | ||||||||
19-20 | ||||||||
20 | ||||||||
20 | ||||||||
20 | ||||||||
20 | ||||||||
21 | ||||||||
22 | ||||||||
Certifications |
23-26 | |||||||
Ex-31.1 Section 302 Certification | ||||||||
Ex-31.2 Section 302 Certification | ||||||||
Ex-32.1 Section 906 Certification | ||||||||
Ex-32.2 Section 906 Certification |
2
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
PART I. FINANCIAL INFORMATION
Item 1 Consolidated Financial Statements
Consolidated Balance Sheets
(Amounts in thousands)
(Amounts in thousands)
February 28, | May 31, | |||||||
2006 | 2005 | |||||||
(unaudited) | ||||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 6,121 | $ | 3,695 | ||||
Restricted cash |
584 | | ||||||
Marketable securities |
3 | 11 | ||||||
Accounts receivable, less allowance for doubtful accounts of $1 and $5,
respectively |
23 | 113 | ||||||
Accounts receivable managed care reinsurance contract |
| 372 | ||||||
Other current assets |
491 | 481 | ||||||
Total current assets |
7,222 | 4,672 | ||||||
Property and equipment, net |
129 | 384 | ||||||
Goodwill, net |
991 | 991 | ||||||
Restricted cash |
| 72 | ||||||
Other assets |
230 | 329 | ||||||
Total assets |
$ | 8,572 | $ | 6,448 | ||||
LIABILITIES AND STOCKHOLDERS DEFICIT |
||||||||
Current liabilities: |
||||||||
Accounts payable and accrued liabilities |
$ | 1,061 | $ | 1,310 | ||||
Accrued claims payable |
3,154 | 3,730 | ||||||
Accrued reinsurance claims payable |
2,749 | 3,191 | ||||||
Income taxes payable |
29 | 30 | ||||||
Total current liabilities |
6,993 | 8,261 | ||||||
Long-term liabilities: |
||||||||
Long-term debt |
2,244 | 2,244 | ||||||
Other liabilities |
20 | 60 | ||||||
Total long-term liabilities |
2,264 | 2,304 | ||||||
Total liabilities |
9,257 | 10,565 | ||||||
Stockholders deficit: |
||||||||
Preferred stock, $50.00 par value; authorized 18,740 shares; issued and
outstanding 14,400 and 0, respectively |
720 | | ||||||
Common stock, $0.01 par value; authorized 12,500,000 shares; issued
and outstanding 5,851,374 and 5,582,547, respectively |
59 | 56 | ||||||
Additional paid-in capital |
56,597 | 53,813 | ||||||
Accumulated deficit |
(58,046 | ) | (57,986 | ) | ||||
Other comprehensive loss |
(15 | ) | | |||||
Total stockholders deficit |
(685 | ) | (4,117 | ) | ||||
Total liabilities and stockholders deficit |
$ | 8,572 | $ | 6,448 | ||||
See accompanying notes to consolidated financial statements.
3
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Consolidated Statements of Operations
(Unaudited)
(Amounts in thousands, except per share amounts)
(Unaudited)
(Amounts in thousands, except per share amounts)
Three Months Ended | Nine Months Ended | |||||||||||||||
February 28, | February 28, | |||||||||||||||
2006 | 2005 | 2006 | 2005 | |||||||||||||
Operating revenues |
$ | 5,585 | $ | 6,241 | $ | 18,642 | $ | 18,511 | ||||||||
Costs and expenses: |
||||||||||||||||
Healthcare operating expenses |
4,579 | 5,134 | 16,074 | 15,630 | ||||||||||||
General and administrative expenses |
768 | 846 | 2,473 | 2,275 | ||||||||||||
Recovery of doubtful accounts |
(55 | ) | ( 2 | ) | (91 | ) | (6 | ) | ||||||||
Depreciation and amortization |
21 | 24 | 65 | 71 | ||||||||||||
5,313 | 6,002 | 18,521 | 17,970 | |||||||||||||
Operating income before items shown below |
272 | 239 | 121 | 541 | ||||||||||||
Other income (expense): |
||||||||||||||||
Loss from software development |
(102 | ) | | (102 | ) | | ||||||||||
Interest income |
19 | 4 | 47 | 9 | ||||||||||||
Interest expense |
(45 | ) | (51 | ) | (139 | ) | (157 | ) | ||||||||
Other non-operating income |
1 | 33 | 57 | 55 | ||||||||||||
Income (loss) before income taxes |
145 | 225 | (16 | ) | 448 | |||||||||||
Income tax expense |
16 | 13 | 44 | 42 | ||||||||||||
Net income (loss) attributable to common shareholders |
$ | 129 | $ | 212 | $ | (60 | ) | $ | 406 | |||||||
Income (loss) per common share basic: |
$ | 0.02 | $ | 0.04 | $ | (0.01 | ) | $ | 0.09 | |||||||
Income (loss) per common share diluted: |
$ | 0.01 | $ | 0.04 | $ | (0.01 | ) | $ | 0.08 | |||||||
Weighted average common shares outstanding: |
||||||||||||||||
Basic |
5,851 | 4,794 | 5,782 | 4,722 | ||||||||||||
Diluted |
10,443 | 5,316 | 5,782 | 5,285 | ||||||||||||
See accompanying notes to consolidated financial statements.
4
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Consolidated Statements of Cash Flows
(Unaudited)
(Amounts in thousands)
(Unaudited)
(Amounts in thousands)
Nine Months Ended | ||||||||
February 28, | ||||||||
2006 | 2005 | |||||||
Cash flows from operating activities: |
||||||||
Net (loss) income from continuing operations |
$ | (60 | ) | $ | 406 | |||
Adjustments to reconcile net (loss) income from continuing operations
to net cash (used in) provided by operating activities: |
||||||||
Depreciation and amortization |
65 | 71 | ||||||
Loss from software development |
102 | | ||||||
Compensation expense stock, stock options and warrants issued |
26 | 30 | ||||||
Amortization of deferred revenue |
(56 | ) | (43 | ) | ||||
Changes in assets and liabilities: |
||||||||
Accounts receivable, net |
90 | (73 | ) | |||||
Accounts receivable managed care reinsurance contract |
372 | 207 | ||||||
Other current assets, restricted cash, and other assets |
(323 | ) | 251 | |||||
Accounts payable and accrued liabilities |
(146 | ) | (145 | ) | ||||
Accrued claims payable |
(576 | ) | (138 | ) | ||||
Accrued reinsurance claims payable |
(442 | ) | 72 | |||||
Income taxes payable |
(1 | ) | 2 | |||||
Other liabilities |
| (1 | ) | |||||
Net cash (used in) provided by continuing operations |
(949 | ) | 639 | |||||
Net cash used in discontinued operations |
(55 | ) | (112 | ) | ||||
Net cash (used in) provided by continuing and discontinued
operations |
(1,004 | ) | 527 | |||||
Cash flows from investing activities: |
||||||||
Additions to property and equipment |
(13 | ) | (29 | ) | ||||
Net cash used in investing activities |
(13 | ) | (29 | ) | ||||
Cash flows from financing activities: |
||||||||
Proceeds
from the issuance of common and preferred stock |
3,481 | 769 | ||||||
Repayment of long-term debt |
(38 | ) | (37 | ) | ||||
Net cash provided by financing activities |
3,443 | 732 | ||||||
Net increase in cash and cash equivalents |
2,426 | 1,230 | ||||||
Cash and cash equivalents at beginning of period |
3,695 | 3,209 | ||||||
Cash and cash equivalents at end of period |
$ | 6,121 | $ | 4,439 | ||||
Supplemental disclosures of cash flow information: |
||||||||
Cash paid during the nine month period for: |
||||||||
Interest |
$ | 97 | 114 | |||||
Income taxes |
$ | 45 | 48 | |||||
Non-cash financing and investing activities: |
||||||||
Warrants issued in connection with issuance of common stock |
$ | | 234 | |||||
Securities received through consulting agreement, net of other
comprehensive loss |
$ | 4 | | |||||
Property and equipment acquired under capital leases |
$ | | 43 | |||||
See accompanying notes to consolidated financial statements.
5
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Note 1 Summary of Significant Accounting Policies
The consolidated balance sheet as of February 28, 2006, and the related consolidated
statements of operations and cash flows for the nine months ended February 28, 2006 and 2005 are
unaudited and have been prepared in accordance with accounting principles generally accepted in the
United States of America for interim financial information and with the instructions to Form 10-Q
and Article 10 of Regulation S-X. In the opinion of management, all adjustments necessary for a
fair presentation of such consolidated financial statements have been included. Such adjustments
consisted only of normal recurring items. The results of operations for the nine months ended
February 28, 2006 are not necessarily indicative of the results to be expected during the remainder
of the fiscal year.
The consolidated financial statements do not include all information and footnotes necessary
for a complete presentation of financial position, results of operations and cash flows in
conformity with accounting principles generally accepted in the United States of America. The
consolidated balance sheet at May 31, 2005 has been derived from the audited, consolidated
financial statements at that date, but does not include all of the information and footnotes
required by accounting principles generally accepted in the United States of America for complete
financial statement presentation. Notes to consolidated financial statements included in Form 10-K
for the fiscal year ended May 31, 2005 are on file with the Securities and Exchange Commission
(SEC) and provide additional disclosures and a further description of accounting policies.
Marketable Securities
The Companys marketable securities are classified as available for sale, and accordingly
are reflected in the consolidated balance sheet at fair market value, with the unrealized loss
included as other comprehensive loss within stockholders deficit.
Restricted Cash
At February 28, 2006, restricted cash consists of a $510,000 deposit required under the terms
of a contract with one existing client for the purpose of paying claims within the next twelve
months, and a $74,000 deposit required in accordance with the Companys Tampa office lease, which
expires May 31, 2006.
Revenue Recognition
The Companys managed care activities are performed under the terms of agreements with health
maintenance organizations (HMOs), preferred provider organizations, and other health plans or
payers to provide contracted behavioral healthcare services to subscribing participants. Revenue
under a substantial portion of these agreements is earned monthly based on the number of qualified
participants regardless of services actually provided (generally referred to as capitation
arrangements). The information regarding qualified participants is supplied by the Companys
clients and the Company relies extensively on the accuracy of the client remittance and other
reported information to determine the amount of revenue to be recognized. Such agreements accounted
for 96.0%, or $17.9 million, of revenue for the nine months ended February 28, 2006 and 88.5%, or
$16.4 million, of revenue for the nine months ended February 28, 2005. The remaining balance of
the Companys revenues is earned on a fee-for-service basis and is recognized as services are
rendered.
Healthcare Expense Recognition
Healthcare operating expense is recognized in the period in which an eligible member actually
receives services and includes an estimate of the cost of behavioral health services that have been
incurred but not yet reported. See Accrued Claims Payable for a discussion of claims incurred
but not yet reported. The Company contracts with various healthcare providers including hospitals,
physician groups and other managed care organizations either on a sub-capitated, a discounted
fee-for-services, or a per-case basis. The Company determines that a member has received services
when the Company receives a claim within the contracted timeframe with all required billing
elements correctly completed by the service provider. The Company then determines that the member
is eligible to receive such services, the service provided is medically necessary and is covered by
the benefit plans certificate of coverage, and the service is authorized by one of our employees.
If all of these requirements are met, the claim is entered into the Companys claims system for
payment.
6
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Accrued Claims Payable
The accrued claims payable liability represents the estimated ultimate net amounts owed for
all behavioral healthcare services provided through the respective balance sheet dates, including
estimated amounts for claims incurred but not yet reported (IBNR) to the Company. The unpaid
claims liability is estimated using an actuarial paid completion factor methodology and other
statistical analyses and is continually reviewed and adjusted, if necessary, to reflect any change
in the estimated liability. These estimates are subject to the effects of trends in utilization and
other factors. However, actual claims incurred could differ from the estimated claims payable
amount reported as of February 28, 2006 and May 31, 2005. Although considerable variability is
inherent in such estimates, management believes that the unpaid claims liability is adequate.
Premium Deficiencies
The Company accrues losses under its capitated contracts when it is probable that a loss has
been incurred and the amount of the loss can be reasonably estimated. The Company performs this
loss accrual analysis on a specific contract basis taking into consideration such factors as future
contractual revenue, projected future healthcare and maintenance costs, and each contracts
specific terms related to future revenue increases as compared to expected increases in healthcare
costs. The projected future healthcare and maintenance costs are estimated based on historical
trends and the Companys estimate of future cost increases.
At any time prior to the end of a contract or contract renewal, if a capitated contract is not
meeting its financial goals, the Company generally has the ability to cancel the contract with 60
to 90 days written notice. Prior to cancellation, the Company will usually submit a request for a
rate increase accompanied by supporting utilization data. Although historically the Companys
clients have been generally receptive to such requests, no assurance can be given that such
requests will be fulfilled in the future in the Companys favor. If a rate increase is not
granted, the Company has the ability to terminate the contract as described above and limit its
risk to a short-term period.
On a quarterly basis, the Company performs a review of its portfolio of contracts for the
purpose of identifying loss contracts (as defined in the American Institute of Certified Public
Accountants Audit and Accounting Guide Health Care Organizations) and developing a contract loss
reserve, if applicable, for succeeding periods. During the nine months ended February 28, 2006, the
Company did not have any contracts where it was probable that a loss had been incurred and for
which a loss could reasonably be estimated.
Income Taxes
The Company has adopted Statement of Financial Accounting Standards (SFAS) No. 109,
Accounting for Income Taxes. Under the asset and liability method of SFAS No. 109, deferred tax
assets and liabilities are recognized for the future tax consequences attributable to net operating
loss carryforwards and to differences between the financial statement carrying amounts of existing
assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those
temporary differences are expected to be recovered or settled. Under SFAS No. 109, the effect of a
change in tax rates on deferred tax assets or liabilities is recognized in the consolidated
statements of operations in the period that included the enactment. A valuation allowance is
established for deferred tax assets unless their realization is considered more likely than not.
Stock Options
The Company issues stock options to its employees and non-employee directors (optionees)
allowing optionees to purchase the Companys common stock pursuant to shareholder-approved stock
option plans. As permitted by Statement of Financial Accounting Standards (SFAS) No. 148,
Accounting for Stock-Based Compensation-Transitional Disclosure, the Company has elected to
follow Accounting Principles Board Opinion No. 25, (APB 25) Accounting for Stock Issued to
Employees and related interpretations in accounting for its employee stock options. Under APB 25,
in the event that the exercise price of the Companys employee stock options is less than the
market price of the underlying stock on the date of grant, compensation expense is recognized. No
stock-based employee compensation cost is reflected in net income (loss), as all options granted
under the Companys employee stock options plans had an exercise price equal to the market value of
the underlying common stock on the date of grant. The following table illustrates the effect on net
income (loss) and income (loss) per share if the Company had applied the fair value recognition
provisions of SFAS No. 148 to stock-based employee compensation.
7
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Three | Three | Nine | Nine | |||||||||||||
Months | Months | Months | Months | |||||||||||||
Ended | Ended | Ended | Ended | |||||||||||||
2/28/06 | 2/28/05 | 2/28/06 | 2/28/05 | |||||||||||||
Net income (loss), as reported |
$ | 129 | $ | 212 | $ | (60 | ) | $ | 406 | |||||||
Deduct: |
||||||||||||||||
Total stock-based employee compensation expense determined
under fair value based method for all awards, net of related tax
effects |
(105 | ) | (77 | ) | (133 | ) | (160 | ) | ||||||||
Pro forma net income (loss) |
$ | 24 | $ | 135 | $ | (193 | ) | $ | 246 | |||||||
Income (loss) per common share: |
||||||||||||||||
Basic as reported |
$ | 0.02 | $ | 0.04 | $ | (0.01 | ) | $ | 0.09 | |||||||
Diluted as reported |
$ | 0.01 | $ | 0.04 | $ | (0.01 | ) | $ | 0.08 | |||||||
Basic pro forma |
$ | 0.00 | $ | 0.03 | $ | (0.03 | ) | $ | 0.05 | |||||||
Diluted pro forma |
$ | 0.00 | $ | 0.03 | $ | (0.03 | ) | $ | 0.05 | |||||||
Per Share Data
In calculating basic income (loss) per share, net income (loss) is divided by the weighted
average number of common shares outstanding for the period. Diluted income (loss) per share
reflects the assumed exercise or conversion of all dilutive securities, such as options, warrants,
convertible debentures, and convertible preferred stock. No such exercise or conversion is assumed
where the effect is antidilutive, such as when there is a net loss. The following table sets forth
the computation of basic and diluted income (loss) per share in accordance with Statement No. 128,
Earnings Per Share: (amounts in thousands, except per share data)
Three Months Ended | Nine Months Ended | |||||||||||||||
February 28, | February 28, | |||||||||||||||
2006 | 2005 | 2006 | 2005 | |||||||||||||
Numerator: |
||||||||||||||||
Numerator for diluted income (loss) attributable to common
stockholders |
$ | 129 | $ | 212 | $ | (60 | ) | $ | 406 | |||||||
Denominator: |
||||||||||||||||
Weighted average shares |
5,851 | 4,794 | 5,782 | 4,722 | ||||||||||||
Effect of dilutive securities: |
||||||||||||||||
Warrants |
14 | 2 | | 2 | ||||||||||||
Employee stock options |
342 | 520 | | 561 | ||||||||||||
Convertible preferred stock |
4,236 | | | | ||||||||||||
Denominator for diluted income (loss) per share-adjusted
weighted average shares after assumed conversions |
10,443 | 5,316 | 5,782 | 5,285 | ||||||||||||
Basic income (loss) per share: |
$ | 0.02 | $ | 0.04 | $ | (0.01 | ) | $ | 0.09 | |||||||
Diluted income (loss) per share: |
$ | 0.01 | $ | 0.04 | $ | (0.01 | ) | $ | 0.08 | |||||||
8
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Authorized shares of common stock reserved for possible issuance for convertible debentures,
convertible preferred stock, stock options, and warrants are as follows at February 28, 2006:
Convertible debentures(a) |
12,377 | |||
Convertible preferred stock(b) |
4,235,328 | |||
Outstanding stock options(c) |
1,093,740 | |||
Outstanding warrants(d) |
406,000 | |||
Possible future issuance under stock option plans |
568,336 | |||
Total |
6,315,781 | |||
(a) | The debentures are convertible into 12,377 shares of common stock at a conversion price of $181.30 per share. | |
(b) | The Series A Convertible Preferred Stock (Series A Preferred Stock) is convertible into 4,235,328 shares of common stock at a conversion rate of 294.12 common shares for each preferred share. | |
(c) | Options to purchase common stock of the Company have been issued to employees and non-employee Board of Director members with exercise prices ranging from $0.25 to $4.00. | |
(d) | Warrants to purchase common stock of the Company have been issued to certain individuals or vendors in exchange for consulting services. All such warrants were issued in lieu of cash compensation and have five-year terms with exercise prices ranging from $1.09 to $5.00 |
Note 2 Liquidity
During the nine months ended February 28, 2006, net cash used in continuing and discontinued
operations amounted to $949,000 and $55,000, respectively. In addition, $3.4 million was provided
by financing activities, primarily from the sale of 14,400 shares of Series A Preferred Stock in
June 2005.
During the nine months ended February 28, 2006 the Company generated operating income of
$121,000 but incurred a net loss of $60,000. As of February 28, 2006, the Company had a positive
net working capital position of $229,000 and a stockholders deficit of $685,000. Effective June
14, 2005, the Company completed a sale of 14,400 shares of its Series A Preferred Stock to
Woodcliff Healthcare Investment Partners, LLC (Woodcliff) for approximately $3.4 million in net
cash proceeds to the Company. As a result, management believes the Company has sufficient working
capital to sustain current operations and to meet the Companys current obligations during fiscal
2006.
Note 3 Total Comprehensive Income (Loss)
Total comprehensive income (loss), defined as net income (loss) adjusted for the unrealized
holding losses on available-for-sale securities, is as follows: (amounts in thousands)
Three Months | Three Months | Nine Months | Nine Months | |||||||||||||
Ended | Ended | Ended | Ended | |||||||||||||
2/28/06 | 2/28/05 | 2/28/06 | 2/28/05 | |||||||||||||
Net income (loss) |
$ | 129 | $ | 212 | $ | (60 | ) | $ | 406 | |||||||
Other comprehensive loss: |
||||||||||||||||
Unrealized holding loss |
(7 | ) | (61 | ) | (15 | ) | (112 | ) | ||||||||
Total comprehensive income (loss) |
$ | 122 | $ | 151 | $ | (75 | ) | $ | 294 | |||||||
Note 4 Sources Of Revenue
The Companys revenue can be segregated into the following significant categories: (amounts in
thousands)
Three Months | Three Months | Nine Months | Nine Months | |||||||||||||
Ended | Ended | Ended | Ended | |||||||||||||
2/28/06 | 2/28/05 | 2/28/06 | 2/28/05 | |||||||||||||
Capitated contracts |
$ | 5,412 | $ | 5,573 | $ | 17,889 | $ | 16,376 | ||||||||
Non-capitated contracts |
173 | 668 | 753 | 2,135 | ||||||||||||
Total |
$ | 5,585 | $ | 6,241 | $ | 18,642 | $ | 18,511 | ||||||||
9
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Capitated revenues include contracts under which the Company assumes the financial risk for
the costs of member behavioral healthcare services in exchange for a fixed, per member per month
fee. For non-capitated contracts, the Company may manage behavioral healthcare programs or perform
various managed care functions, such as clinical care management, provider network development, and
claims processing without assuming financial risk for member behavioral healthcare costs.
Note 5 Major Customers/Contracts
(1) Effective December 31, 2005, the Company experienced the loss of a major contract to
provide behavioral healthcare services to the members of a Connecticut HMO. This agreement
represented approximately 18.0%, or $3.4 million, and 21.1%, or $3.9 million, of the Companys
operating revenue for the nine months ended February 28, 2006 and 2005, respectively.
Additionally, this contract provided that the Company, through its contract with this HMO, received
additional funds directly from a state reinsurance program for the purpose of paying providers.
During the nine months ended February 28, 2006 and 2005, the Company filed reinsurance claims
totaling approximately $1.2 million and $2.2 million, respectively. Such claims represent cost
reimbursements and, as such, are not included in the reported operating revenues and are accounted
for as reductions of healthcare operating expenses. As of February 28, 2006 and May 31, 2005, the
Company has reported $0 and $372,000 as accounts receivablemanaged care reinsurance contracts,
with $2.7 million and $3.2 million, respectively, reported as accrued reinsurance claims payable in
the accompanying balance sheet. The difference between the reinsurance receivable amount and the
reinsurance payable amount is related to timing differences between the authorization date, the
date the money is received by the Company, and the date the money is paid to the provider. In
certain cases, providers have submitted claims for authorized services having incorrect service
codes or otherwise incorrect information that has caused payment to be denied by the Company. In
such cases, there are contractual and statutory provisions that allow the provider to appeal a
denied claim. If there is no appeal received by the Company within the prescribed amount of time,
the Company may be required to remit the reinsurance funds back to the appropriate party. Accrued
amounts for non-reinsurance claims incurred but not yet reported are estimated using methods
similar to that used for other existing contracts, and totaled approximately $0.5 million as of
February 28, 2006. This HMO had been a customer since March 2001.
(2) The Company has contracts with one HMO to provide behavioral healthcare services to
contracted commercial, Medicaid, and Childrens Health Insurance Program (CHIP) members in Texas.
This business accounted for approximately 22.2%, or $4.1 million, and 21.1%, or $3.9 million, of
the Companys operating revenues during the nine months ended February 28, 2006 and February 28,
2005, respectively. This HMO has been a customer of the Company since November 1998. On January
25, 2006, the Company received written notice from the client that it had determined to establish
its own behavioral health unit and therefore was canceling the contract effective May 31, 2006.
In general, the Companys contracts with its customers are typically for initial one-year terms,
with automatic annual extensions. Such contracts generally provide for cancellation by either
party with 60 to 90 days written notice.
Note 6 Preferred Stock
As of February 28, 2006, there are 4,340 remaining shares authorized and available to issue,
and 14,400 outstanding shares of Series A Preferred Stock. All outstanding shares were issued in
June 2005 as a result of the sale of Series A Preferred Stock to Woodcliff for approximately $3.4
million in net cash proceeds (see Managements Discussion and Analysis of Financial Condition and
Results of Operations). The Company is authorized to issue shares of Preferred Stock, $50.00 par
value, in one or more series, each series to have such designation and number of shares as the
Board of Directors may fix prior to the issuance of any shares of such series. Each series may
have such preferences and relative participation, optional or special rights with such
qualifications, limitations or restrictions stated in the resolution or resolutions providing for
the issuance of such series as may be adopted from time to time by the Board of Directors prior to
the issuance of any such series.
Note 7 Commitments and Contingencies
(1) In connection with the Companys Preferred Provider Network license in Connecticut,
the Company is required to maintain a performance bond during all applicable terms of the license.
As such, the Company maintains a performance bond of $2,400,000 in compliance with this
requirement. In addition, a contract with one existing client requires the Company to maintain two
performance bonds totaling $330,000 throughout the contract term.
10
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
(2) Related to the Companys discontinued hospital operations, Medicare guidelines allow
the Medicare fiscal intermediary to re-open previously filed cost reports. Management believes
that the Companys fiscal 1998 and 1999 cost reports remain eligible for re-opening at some future
date, in which case the intermediary may determine that additional amounts are due to or from
Medicare.
(3) The Company is subject to the requirements of the Health Insurance Portability and
Accountability Act of 1996 (HIPAA). The purpose of the HIPAA provisions is to improve the
efficiency and effectiveness of the healthcare system through standardization of the electronic
data interchange of certain administrative and financial transactions and, also, to protect the
security and privacy of protected health information. Entities subject to HIPAA include some
healthcare providers and all healthcare plans. To meet the specific requirements of HIPAA, the
Company implemented an immediate but temporary solution designed by a new vendor. The Company then
entered into an agreement to engage this vendor to design a new, customized management information
system that would enable the Company to meet HIPAA requirements in the future. As of February
28, 2006 the Company had paid the vendor $200,000 of the expected $370,000 in total costs of the
system. In March 2006 the vendor informed the Company that it would not be able to complete the
design of the information system within the timeframe required by the Company to meet future
information system needs. In its place the Company will modify its existing healthcare information
system with recently made available enhancements to best meet the Companys future information
system needs and all HIPAA requirements. Due to favorable pricing terms offered by the vendor of
the existing system, the Company expects the modifications to require minimal additional
investment. The Company is seeking a refund of monies paid towards the new system but believes it
is probable that it will not recover its full investment and accordingly has recorded managements
best estimate of the contingent loss in the accompanying unaudited, consolidated statement of
operations described as a loss from software development.
(4) The Company is actively marketing eye care memberships it acquired in November 2004.
If the Companys marketing plan is unsuccessful with respect to these memberships, it may have to
write off some or all of the $125,000 the Company paid to acquire them. While management believes
the Companys marketing efforts will be successful, there can be no assurance the Company will sell
a quantity of memberships at prices that will allow the Company to recover the $125,000 cost.
(5) Effective August 1, 2005, the Companys principal operating subsidiary, Comprehensive
Behavioral Care (CBC), entered into a marketing agreement with Health Alliance Network, Inc.
(HAN) whereby CBC has agreed to appoint HAN as its primary representative and marketing agent for
commercial business (see Managements Discussion and Analysis of Financial Condition and Results of
Operations). Two shareholders of HAN are members of Woodcliff, the investor in our Series A
Preferred Stock in June 2005.
From time to time, the Company and its subsidiaries are also parties to and their property is
subject to ordinary, routine litigation incidental to their business, in which case claims may
exceed insurance policy limits and the Company or any one of its subsidiaries may have exposure to
a liability that is not covered by insurance. Management is not aware of any such lawsuits that
could have a material adverse impact on the Companys consolidated financial statements.
Note 8 Related Party Transactions
In February 2006 CBC entered into an agreement with Hythiam, Inc. whereby CBC would have the
exclusive right to market Hythiams substance abuse disease management program to its current and
certain mutually agreed upon prospective clients. The program is an integrated disease management
approach designed to offer less restrictive levels of care in order to minimize repeat
detoxifications. Under the agreement, the Company will pay Hythiam license and service fees for
each enrollee who is treated. A Director of the Company is the Vice President of Corporate
Development for Hythiam. As of February 28, 2006 there had been no material transactions
resulting from this agreement.
11
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Item 2 Managements Discussion and Analysis of Financial Condition and Results of
Operations
In addition to historical information, the following information contains forward-looking
statements as defined under federal securities laws. Such statements include, but are not limited
to, statements concerning the Companys anticipated operating results, financial resources,
increases in revenues, increased profitability, interest expense, growth and expansion, and the
ability to obtain new behavioral healthcare contracts. These statements are based on current
expectations, estimates and projections about the industry and markets in which Comprehensive Care
Corporation (CompCare or the Company) operates, and managements beliefs and assumptions.
Forward-looking statements are not guarantees of future performance and involve certain known and
unknown risks and uncertainties that could cause actual results to differ materially from those
expressed or implied by such statements. Such risks and uncertainties include, but are not limited
to, changes in local, regional, and national economic and political conditions, the effect of
governmental regulation, competitive market conditions, varying trends in member utilization, cost
of care, and seasonality, the Companys ability to obtain additional financing, and other risks
detailed herein and from time to time in the Companys SEC reports. The following discussion should
be read in conjunction with the accompanying consolidated financial statements and notes thereto of
CompCare appearing elsewhere herein.
OVERVIEW
General
Comprehensive Care Corporation is a Delaware corporation organized in 1969. The Company,
primarily through its wholly owned subsidiary, Comprehensive Behavioral Care, Inc., provides
managed care services in the behavioral health and psychiatric fields, which is its only operating
segment. We manage the delivery of a continuum of psychiatric and substance abuse services to
commercial, Medicare, and Medicaid members on behalf of employers, health plans, government
organizations, third-party claims administrators, and commercial and other group purchasers of
behavioral healthcare services. The customer base for our services includes both private and
governmental entities. Our services are provided primarily by unrelated vendors on a subcontract
basis.
We typically enter into contracts on an annual basis to provide managed behavioral healthcare
and substance abuse to our clients members. Our arrangements with our clients fall into two broad
categories: capitation arrangements, where our clients pay us a fixed fee per member, and
fee-for-service and administrative service arrangements where we may manage behavioral healthcare
programs or perform various managed care services. We derived 96.0% or $17.9 million of our
revenues from capitation arrangements for the nine months ended February 28, 2006. Under
capitation arrangements, we receive premiums from our clients based on the number of covered
members as reported to us by our clients. The amount of premiums we receive for each member is
fixed at the beginning of the contract term. These premiums may be subsequently adjusted, up or
down, generally at the commencement of each renewal period.
Our largest expense is the cost of behavioral health services that we provide, which is based
primarily on our arrangements with healthcare providers. Since we are subject to increases in
healthcare operating expenses based on an increase in the number and frequency of our members
seeking behavioral care services, our profitability depends on our ability to predict and
effectively manage healthcare operating expenses in relation to the fixed premiums we receive under
capitation arrangements. Providing services on a capitation basis exposes us to the risk that our
contracts may ultimately be unprofitable if we are unable to anticipate or control healthcare
costs. Estimation of healthcare operating expense is our most significant critical accounting
estimate. See Managements Discussion and Analyses of Financial Condition and Results of
Operations Critical Accounting Estimates.
12
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
We currently depend, and expect to continue to depend in the near future, upon a relatively
small number of customers for a significant percentage of our operating revenues. A significant
reduction in sales to any of our large customers or a customer exerting significant pricing and
margin pressures on us would have a material adverse effect on our results of operations and
financial condition. In the past, some of our customers have terminated their arrangements with us
or have significantly reduced the amount of services requested from us. There can be no assurance
that present or future customers will not terminate their arrangements with us or significantly
reduce the amount of services requested from us. Any such termination of a relationship or
reduction in use of our services would have a material adverse effect on our results of operations
or financial condition (see Note 5 Major Customers/Contracts to the unaudited, consolidated
financial statements).
Recent Developments
In February 2006 CBC entered into an agreement with Hythiam, Inc. whereby it would have the
exclusive right to market Hythiams substance abuse disease management program to its current and
certain mutually agreed upon prospective clients. The program is an integrated disease management
approach designed to offer less restrictive levels of care in order to minimize repeat
detoxifications. Hythiam has also agreed to sponsor two sales personnel to promote the program.
In December 2005 the Company experienced the loss of a major contract to provide behavioral
healthcare services to the members of a Connecticut HMO. This agreement represented approximately
18.0%, or $3.4 million, and 21.1%, or $3.9 million, of the Companys operating revenue for the nine
months ended February 28, 2006 and 2005, respectively. As previously disclosed in a filing with
the Securities and Exchange Commission in January 2006, the Company was notified by a major Texas
client that it would establish its own behavioral health unit and therefore was canceling its
contract with the Company effective May 31, 2006. This business accounted for approximately 22.2%,
or $4.1 million, and 21.1%, or $3.9 million, of the Companys operating revenues during the nine
months ended February 28, 2006 and February 28, 2005, respectively. The Company has undertaken
efforts to prepare for the loss of these contracts, including taking steps to reduce the internal
costs and infrastructure associated with these contracts as well as enhancing efforts to obtain new
business. On February 2, 2006 the Company announced that it had been selected by an existing
health plan client to provide managed behavioral health and substance abuse services to
approximately 7,500 Medicare members in Maryland and Washington, D.C. beginning March 1, 2006.
RESULTS OF OPERATIONS
For the nine months ended February 28, 2006, the Company reported a net loss of $60,000, or
$0.01 loss per basic and diluted share. In comparison, the Company reported a net income from
continuing operations of $406,000, or $0.09 earnings per share ($0.08 per diluted share), for the
nine months ended February 28, 2005.
The following tables summarize the Companys operating results from continuing operations for
the three and nine months ended February 28, 2006 and February 28, 2005 (in thousands):
13
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
The Three Months Ended February 28, 2006 Compared to the Three Months Ended February 28,
2005:
Three Months Ended | ||||||||
February 28, | ||||||||
2006 | 2005 | |||||||
Operating revenues: |
||||||||
Capitated contracts |
$ | 5,412 | 5,573 | |||||
Non-capitated sources |
173 | 668 | ||||||
Total operating revenues |
5,585 | 6,241 | ||||||
Operating expenses: |
||||||||
Healthcare operating expenses: |
||||||||
Claims expense(1) |
3,560 | 3,850 | ||||||
Other healthcare operating expenses(1) |
1,019 | 1,284 | ||||||
Total healthcare operating expense |
4,579 | 5,134 | ||||||
General and administrative expenses |
768 | 846 | ||||||
Other operating expenses, net |
(34 | ) | 22 | |||||
Total operating expenses |
5,313 | 6,002 | ||||||
Operating income |
$ | 272 | 239 | |||||
(1) | Claims expense reflects the cost of revenue of capitated contracts, and other healthcare operating expense reflects the cost of revenue of capitated and non-capitated contracts. |
The Company reported operating income of $272,000 and net income of $129,000, or $0.02
earnings per share ($0.01 per diluted share), for the quarter ended February 28, 2006 compared to
operating income of $239,000 and a net income of $212,000, or $0.04 earnings per share (basic and
diluted), for the quarter ended February 28, 2005. Operating revenues from capitated contracts
decreased 2.9%, or approximately $161,000, to $5.4 million for the quarter ended February 28, 2006
compared to $5.6 million for the quarter ended February 28, 2005. This decrease is primarily
attributable to the loss of our Connecticut client, but was partially offset by new revenue of
approximately $525,000 attributable to the Companys new client in Pennsylvania. Revenue from
non-capitated sources declined 74.1% or approximately $495,000 to $173,000 for the three months
ended February 28, 2006, compared to $668,000 for the three months ended February 28, 2005. The
decrease is due to the loss of two management services only customers in Michigan and an ASO client
in Texas.
Claims expense on capitated contracts decreased approximately $290,000 or 7.5% for the quarter
ended February 28, 2006 as compared to the quarter ended February 28, 2005. The reduction is due
to a combination of lower capitated revenues and decreased utilization of covered services.
Utilization, expressed as a percentage of claims expense to capitated revenues, decreased from
69.1% for the three months ended February 28, 2006 to 65.8% for the three months ended February 28,
2005. Other healthcare operating expenses, attributable to servicing both capitated and
non-capitated contracts, decreased 20.6% or approximately $265,000 due to workforce reductions in
response to the aforementioned loss of non-capitated revenues in Michigan and Texas.
General and administrative expenses decreased by $78,000, or 9.2%, for the quarter ended
February 28, 2006 as compared to the quarter ended February 28, 2005. This decrease is primarily
attributable to a decrease in salaries and benefits resulting from the Companys expense reduction
program and less usage of outside professional services. General and administrative expense as a
percentage of operating revenue increased slightly from 13.6% for the quarter ended February 28,
2005 to 13.8% for the quarter ended February 28, 2006 due to the reduction in operating revenues
for the fiscal 2006 quarter.
14
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
The Nine Months Ended February 28, 2006 Compared to the Nine Months Ended February 28,
2005:
Nine Months Ended | ||||||||
February 28, | ||||||||
2006 | 2005 | |||||||
Operating revenues: |
||||||||
Capitated contracts |
$ | 17,889 | 16,376 | |||||
Non-capitated sources |
753 | 2,135 | ||||||
Total operating revenues |
18,642 | 18,511 | ||||||
Operating expenses: |
||||||||
Healthcare operating expenses: |
||||||||
Claims expense(1) |
12,820 | 11,779 | ||||||
Other healthcare operating expenses(1) |
3,254 | 3,851 | ||||||
Total healthcare operating expense |
16,074 | 15,630 | ||||||
General and administrative expenses |
2,473 | 2,275 | ||||||
Other operating expenses, net |
(26 | ) | 65 | |||||
Total operating expenses |
18,521 | 17,970 | ||||||
Operating income |
$ | 121 | 541 | |||||
(1) | Claims expense reflects the cost of revenue of capitated contracts, and other healthcare operating expense reflects the cost of revenue of capitated and non-capitated contracts. |
The Company reported operating income of $121,000 and a net loss of $60,000, or $0.01
loss per basic and diluted share, for the nine months ended February 28, 2006 compared to an
operating income of $541,000 and a net income of $406,000, or $0.09 earnings per share ($0.08 per
diluted share), for the nine months ended February 28, 2005. Capitated contract revenues increased
9.2%, or approximately $1.5 million to approximately $17.9 million for the nine months ended
February 28, 2006 compared to $16.4 million for the nine months ended February 28, 2005. This
increase is primarily attributable to additional business from existing clients in Indiana and one
new customer in Pennsylvania, but was partially offset by the loss of our Connecticut customer.
Non-capitated revenue declined 64.7%, or approximately $1.4 million, to approximately $0.8 million
for the nine months ended February 28, 2006, compared to approximately $2.1 million for the same
period of fiscal 2005. The decrease is attributable to the loss of two management services only
customers in Michigan and an ASO client in Texas.
Claims expense on capitated contracts increased approximately $1.0 million or 8.8% for the
nine months ended February 28, 2006 as compared to the nine months ended February 28, 2005 due to
higher capitated revenues. Claims expense as a percentage of capitated revenues decreased slightly
from 71.9% for the nine months ended February 28, 2005 to 71.7% for the nine months ended February
28, 2006. Other healthcare expenses, which are incurred to service both capitated and non-capitated
contracts, decreased approximately $597,000, or 15.5%, due to staff reductions in response to the
loss of non-capitated revenues in Michigan and Texas.
General and administrative expenses increased by $198,000, or 8.7%, for the nine months ended
February 28, 2006 as compared to the nine months ended February 28, 2005. This increase is
primarily attributable to indirect costs of the June 2005 sale of Series A Preferred Stock,
increased costs for marketing consultants engaged to obtain additional commercial business, and
legal expenses associated with the Companys 2005 Annual Meeting and changes to the corporate
charter. General and administrative expense as a percentage of operating revenue increased from
12.3% for the nine months ended February 28, 2005 to 13.3% for the nine months ended February 28,
2006.
SEASONALITY OF BUSINESS
Historically, we have experienced consistently low utilization by members during our first
fiscal quarter, which comprises the months of June, July, and August, and increased member
utilization during our fourth fiscal quarter, which comprises the months of March, April and May.
Such variations in member utilization impact our costs of care during these months, generally
having a positive impact on our gross margins and operating profits during the first fiscal quarter
and a negative impact on our gross margins and operating profits during the fourth quarter. During
the first quarter of our 2006 fiscal year, we experienced higher than expected utilization costs as
compared to the first quarter in the previous two fiscal years. We have attempted to address the
high utilization costs incurred during our first quarter of this fiscal year through rate increases
with certain of our clients. We cannot provide assurance that we will not continue to experience
increased utilization costs in subsequent quarters.
15
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
CONCENTRATION OF RISK
For the nine months ended February 28, 2006, 86.9% of our operating revenue was concentrated
in contracts with eight health plans to provide behavioral healthcare services under commercial,
Medicare, Medicaid, and CHIP plans. For the same period of the prior fiscal year, 75.9% of our
operating revenue was concentrated in contracts with seven health plans. The terms of each
contract are generally for one-year periods and are automatically renewable for additional one-year
periods unless terminated by either party. The loss of one or more of these clients, without
replacement by new business, could negatively affect the financial condition of the Company.
LIQUIDITY AND CAPITAL RESOURCES
During the nine months ended February 28, 2006, net cash used in continuing and discontinued
operations amounted to $949,000 and $55,000. In comparison, $639,000 was provided by continuing
operations while $112,000 was used in discontinued operations during the nine months ended February
28, 2005. The increase in net cash used in continuing operations is primarily the result of the
Company establishing a restricted cash account in the initial amount of $500,000 in accordance with
the terms of a client contract and the payment of accrued claims payable. During the nine months
ended February 28, 2006, net cash provided by financing activities amounted to $3.4 million, as
compared to $732,000 provided by financing activities for the same period of fiscal 2005. The
change in cash provided by financing activities is primarily attributable to proceeds from the sale
of 14,400 shares of Series A Preferred Stock in June 2005.
At February 28, 2006, cash and cash equivalents were approximately $6.1 million. We also
maintained restricted cash of $584,000 as of February 28, 2006, composed of a deposit required
pursuant to one of our client contracts, and a deposit required in accordance with the Companys
Tampa office lease. During the nine months ended February 28, 2006, we incurred a net loss of
$60,000. As of February 28, 2006, the Company had a positive net working capital position of
$229,000 and a stockholders deficit of $685,000. On June 14, 2005, the Company completed the sale
of 14,400 shares of its Series A Preferred Stock for approximately $3.4 million in net cash
proceeds to the Company. As a result, we believe we have sufficient working capital to sustain
current operations and to meet our current obligations during our 2006 fiscal year without the need
to raise additional equity or debt financing. We expect to meet our working capital needs in our
2007 fiscal year and thereafter with our existing cash balances and
by cash generated from continuing operations.
Our unpaid claims liability is estimated using an actuarial paid completion factor methodology
and other statistical analyses. These estimates are subject to the effects of trends in
utilization and other factors. Any significant increase in member utilization that falls outside
of our estimations would increase healthcare operating expenses and may impact our ability to
sustain profitability and achieve positive cash flow. Although considerable variability is inherent
in such estimates, we believe that our unpaid claims liability is adequate. However, actual results
could differ from the $3.2 million claims payable amount reported as of February 28, 2006.
Our Connecticut contract ended December 31, 2005 (See Recent Developments above). This
contract represented approximately $3.4 million, or 18.0%, of our operating revenue for the nine
months ended February 28, 2006 and approximately $5.3 million, or 21.6%, of our operating revenue
for the fiscal year ended May 31, 2005. While a loss of revenue, such as from our Connecticut HMO
client, may have a material adverse effect on our results of operations and financial condition,
our Connecticut contract typically generated high healthcare operating expenses in relation to the
fixed premiums that we received throughout the entire contract term. Accordingly, we do not expect
to experience an equally significant decline in operating income as a result of losing the
Connecticut business. Furthermore, we have replaced a portion of the revenues from our Connecticut
contract with new business in Pennsylvania, Maryland, and Washington D.C.
Related-Party Transactions
In February 2006, CBC entered into an agreement with Hythiam, Inc. whereby CBC would have
the exclusive right to market Hythiams substance abuse disease management program to its current
and certain mutually agreed upon prospective clients. A Director of the Company is the Vice
President of Corporate Development for Hythiam. For a description of this and our other
related-party transactions, see Note 7(5) and Note 8 to our Consolidated Financial Statements.
16
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
CRITICAL ACCOUNTING ESTIMATES
Our discussion and analysis of our financial condition and results of operations is based upon
the Companys consolidated financial statements, which have been prepared in accordance with
accounting principles generally accepted in the United States of America. The preparation of these
consolidated financial statements requires us to make significant estimates and judgments to
develop the amounts reflected and disclosed in the consolidated financial statements, most notably
our estimate for claims incurred but not yet reported (IBNR). On an on-going basis, we evaluate
the appropriateness of our estimates and we maintain a thorough process to review the application
of our accounting policies. We base our estimates on historical experience and on various other
assumptions that we believe to be reasonable under the circumstances. Actual results may differ
from these estimates under different assumptions or conditions.
We believe our accounting policies specific to our accrued claims payable and revenue
recognition involve our most significant judgments and estimates that are material to our
consolidated financial statements (see Note 1 Summary of Significant Accounting Policies to the
unaudited, consolidated financial statements).
Revenue Recognition
We provide managed behavioral healthcare and substance abuse services to recipients, primarily
through subcontracts with HMOs. Revenue under the vast majority of these agreements is earned and
recognized monthly based on the number of covered members as reported to us by our clients
regardless of whether services actually provided are lesser or greater than anticipated when we
entered into such contracts (generally referred to as capitation arrangements). The information
regarding the number of covered members is supplied by the Companys clients and the Company relies
extensively on the accuracy of this information when calculating the amount of revenue to be
recognized. Consequently, the vast majority of the Companys revenue is determined by the
monthly receipt of covered member information and the associated payment from the client, thereby
removing uncertainty and precluding the Company from needing to make assumptions to estimate
monthly revenue amounts.
We may experience adjustments to our revenues to reflect changes in the number and eligibility
status of members subsequent to when revenue is recognized. Subsequent adjustments to the
Companys revenue have not been material.
Accrued Claims Payable and Claims Expense
Healthcare operating expenses are composed of claims expense and other healthcare expenses.
Claims expense includes amounts paid to hospitals, physician groups and other managed care
organizations under capitated contracts. Other healthcare expenses include items such as
information systems, case management and quality assurance, attributable to both capitated and
non-capitated contracts.
The cost of behavioral health services is recognized in the period in which an eligible member
actually receives services and includes an estimate of IBNR (as defined below). The Company
contracts with various healthcare providers including hospitals, physician groups and other managed
care organizations either on a sub-capitated, a discounted fee-for-services, or a per-case basis.
The Company determines that a member has received services when the Company receives a claim within
the contracted timeframe with all required billing elements correctly completed by the service
provider. The Company then determines whether (1) the member is eligible to receive such services,
(2) the service provided is medically necessary and is covered by the benefit plans certificate of
coverage, and (3) the service has been authorized by one of our employees. If all of these
requirements are met, the claim is entered into the Companys claims system for payment and the
associated cost of behavioral health services is recognized.
Accrued claims payable consists primarily of reserves established for reported claims and
claims incurred but not yet reported (IBNR), which are unpaid through the respective balance
sheet dates. Our policy is to record managements best estimate of IBNR. The IBNR liability is
estimated monthly using an actuarial paid completion factor methodology and is continually reviewed
and adjusted, if necessary, to reflect any change in the estimated liability as more information
becomes available. In deriving a range of estimates, management considers qualitative factors,
authorization information, and an actuarial model that incorporates past claims payment experience,
enrollment data and key assumptions such as trends in healthcare costs and seasonality. The
accrued claims payable
ranges were between $2.5 and $3.2 million at February 28, 2006 and between $3.5 and $3.8 million at
May 31, 2005. To determine the best estimates, management reviews utilization statistics,
authorized healthcare service data,
17
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
calculated completion factors and other data available at and
subsequent to the balance sheet dates. The best estimate at February 28, 2006 was $3.2 million and
at May 31, 2005, $3.7 million. The Company has used the same methodology and assumptions for
estimating the IBNR portion of the accrued claims liability for each fiscal quarter-end.
Accrued claims payable at February 28, 2006 and May 31, 2005 comprises approximately $1.2
million and, $1.8 million, respectively, of submitted and approved claims which had not yet been
paid, and $2.0 million and, $1.9 million for IBNR claims, respectively.
Many aspects of our business are not predictable with consistency, and therefore, estimating
IBNR claims involves a significant amount of management judgment. Actual claims incurred could
differ from the estimated claims payable amount presented. The following are factors that would
have an impact on future operations and financial condition of the Company:
| Changes in utilization patterns | ||
| Changes in healthcare costs | ||
| Changes in claims submission timeframes by providers | ||
| Success in renegotiating contracts with healthcare providers | ||
| Occurrence of catastrophes | ||
| Changes in benefit plan design | ||
| The impact of present or future state and federal regulations |
A 5% increase in assumed healthcare cost trends from those used in our calculations of IBNR at
February 28, 2006 could increase our claims expense by
approximately $72,000 and reduce our net
results per share by $0.01 as illustrated in the table below:
Change in Healthcare Costs:
(Decrease) | ||||
(Decrease) | Increase | |||
Increase | In Claims Expense | |||
(5%) | ($74,000 | ) | ||
5% | $72,000 |
Premium Deficiencies
The Company accrues losses under its capitated contracts when it is probable that a loss has
been incurred and the amount of the loss can be reasonably estimated. The Company performs this
loss accrual analysis on a specific contract basis taking into consideration such factors as future
contractual revenue, projected future healthcare and maintenance costs, and each contracts
specific terms related to future revenue increases as compared to expected increases in healthcare
costs. The projected future healthcare and maintenance costs are estimated based on historical
trends and the Companys estimate of future cost increases.
At any time prior to the end of a contract or contract renewal, if a capitated contract is not
meeting its financial goals, the Company generally has the ability to cancel the contract with 60
to 90 days written notice. Prior to cancellation, the Company will usually submit a request for a
rate increase accompanied by supporting utilization data. Although the Companys clients have
historically been generally receptive to such requests, no assurance can be given that such
requests will be fulfilled in the future in the Companys favor. If a rate increase is not
granted, the Company has the ability to terminate the contract and limit its risk to a short-term
period.
On a quarterly basis, the Company performs a review of its portfolio of contracts for the
purpose of identifying loss contracts (as defined in the American Institute of Certified Public
Accountants Audit and Accounting Guide Health Care Organizations) and developing a contract loss
reserve, if applicable, for succeeding periods. During the nine months ended February 28, 2006, the
Company did not have any contracts where it was probable that a loss had been incurred and for
which a loss could reasonably be estimated.
18
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Marketable Securities
In assessing the carrying value of a marketable security classified as available for sale
where the securitys market value is less than its carrying value, we will make a determination if
the decline is other than temporary by considering:
| The financial condition of the issuer. | ||
| The length of time the investment has been in a continuous unrealized position. | ||
| The Companys ability to hold the security for a period of time sufficient to allow for any anticipated recovery. |
Goodwill
The Company evaluates at least annually the amount of its recorded goodwill by performing an
impairment test that compares the carrying amount to an estimated fair value. In estimating the
fair value, management makes its best assumptions regarding future cash flows and a discount rate
to be applied to the cash flows to yield a present, fair value of equity. As a result of such
tests, management believes there is no material risk of loss from impairment of goodwill. However,
actual results may differ significantly from managements assumptions, resulting in potentially
adverse impact to the Companys consolidated financial statements.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
While we currently have market risk sensitive instruments, we have no significant exposure to
changing interest rates as the interest rate on our long-term debt is fixed. Additionally, we do
not use derivative financial instruments for investment or trading purposes and our investments are
generally limited to cash deposits.
Item 4. Controls and Procedures
Under the supervision and with the participation of the Companys Chief Executive Officer and
Chief Financial Officer, the Company has evaluated the effectiveness of the design and operation of
its disclosure controls and procedures as of the end of the period covered by this report, and,
based on their evaluation, the Chief Executive Officer and Chief Financial Officer have concluded
that these disclosure controls and procedures are effective. There have been no changes in the
Companys internal controls over financial reporting identified in connection with this evaluation
that occurred during the period covered by this report and that have affected, or are reasonably
likely to materially affect, the Companys internal controls over financial reporting.
PART II OTHER INFORMATION
Item 1. Legal Proceedings
From time to time, the Company and its subsidiaries may be parties to and their property
subject to ordinary, routine litigation incidental to their business, in which case claims may
exceed insurance policy limits and the Company or any one of its subsidiaries may have exposure to
a liability that is not covered by insurance. Management is not aware of any such lawsuits that
could have a material adverse impact on the Companys consolidated financial statements.
Item 1A. Risk Factors
The Risk Factors included in the Companys Annual Report on Form 10-K for the fiscal year ended May
31, 2005 have not materially changed other than as set forth below.
We depend on a limited number of customers, the loss of any one of these customers, or a reduction
in business from any one of them, could have a material, adverse effect on our working capital and
future results of operations.
For the nine months ended February 28, 2006, a significant portion of our revenue was
attributable to contracts with eight health plans to provide behavioral healthcare services under
commercial, Medicare, Medicaid, and CHIP plans. These combined contracts represented approximately
86.9% and 75.9% of our operating revenue for
19
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
the nine months ended February 28, 2006 and February
28, 2005, respectively, two of which each represented
approximately 20% of our operating revenues for the same periods. The terms of each contract
are generally for one-year periods and are automatically renewable for additional one-year periods
unless terminated by either party. The loss of one or more of these clients, without replacement by
new business, would negatively affect the financial condition of the Company.
As described in Note 5 Major Customers/Contracts to the unaudited, consolidated financial
statements, our contract with a Connecticut HMO terminated December 31, 2005. This contract
represented approximately $3.4 million, or 18.0%, of our operating revenue for the nine months
ended February 28, 2006 and approximately $5.3 million, or 21.6%, of our operating revenue for the
fiscal year ended May 31, 2005. Our Connecticut contract typically generated high healthcare
operating expenses in relation to the fixed premiums that we received throughout the entire
contract term. Accordingly, we do not expect to experience an equally significant decline in
operating income as a result of losing the Connecticut business. Furthermore, a portion of the
revenues from the Connecticut contract have been replaced by new business in Pennsylvania,
Maryland, and Washington D.C.
As additionally described in Note 5(1) Major Customers/Contracts to the accompanying
unaudited, consolidated financial statements, we have been notified that our contracts with a Texas
HMO to provide behavioral healthcare services to contracted commercial, Medicaid, and CHIP members
will terminate May 31, 2006. These contracts accounted for approximately $4.1 million, or 22.2% of
our operating revenues for the nine months ended February 28, 2006, and $5.2 million, or 21.5% of
operating revenues during the fiscal year ended May 31, 2005. Unless replaced with business of
similar volume, the loss of these contracts will adversely affect our operating income.
Our inability to recover amounts paid to an information system vendor exposes the Company to
further impairment.
We are seeking a refund from an information system vendor relating to such vendors failure to
complete the design and implementation of a new information system. Based on managements
assessment of the recoverability of the amounts paid, we have recorded an impairment and a
corresponding loss in the accompanying financial statements as of February 28, 2006. To the extent
we are not refunded the remaining amount we have recorded as recoverable, we will record future
impairments. See Note 7(3) Commitments and Contingencies to our unaudited, consolidated
financial statements.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
On December 1, 2005, the Company issued 1,000 shares of its common stock in exchange for
marketing services provided to the Company by a vendor who accepted the shares in lieu of $2,000 in
cash compensation. The foregoing sale of securities was made in reliance upon the exemptions from
the registration provisions of the Securities Act of 1933, as amended, provided for by Section 4(2)
thereof for transactions not involving a public offering.
Item 3. Defaults Upon Senior Securities
Not applicable.
Item 4. Submission of Matters to a Vote of Security Holders
On February 14, 2006, the holders of 54.1% of the outstanding voting capital stock, voting
together as a single class, and the holders of all outstanding shares of CompCares Series A
Convertible Preferred Stock, par value $50.00 per share, voting as a separate class, by written
consent in lieu of a special meeting of the stockholders, ratified and approved an amendment to
CompCares Non-Employee Director Stock Option Plan and an amendment to the Companys Restated
Certificate of Incorporation increasing its authorized shares of common stock from 12,500,000 to
30,000,000. All stockholders were notified of the proposed amendment by an information statement
on Schedule 14C mailed on March 3, 2006. Further information concerning these matters is contained
in the Information Statement as filed with the Securities and Exchange Commission and available at
www.sec.gov.
Item 5. Other Information
Not applicable.
20
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Item 6. Exhibits
EXHIBIT | ||||||
NUMBER | DESCRIPTION | PAGE NUMBER | ||||
31.1 |
Comprehensive Care Corporation CEO Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | 23 | ||||
31.2 |
Comprehensive Care Corporation CFO Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | 24 | ||||
32.1 |
Comprehensive Care Corporation CEO Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | 25 | ||||
32.2 |
Comprehensive Care Corporation CFO Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | 26 |
21
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly
caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
COMPREHENSIVE CARE CORPORATION | ||||||
April 14, 2006 |
||||||
By | /s/ Mary Jane Johnson | |||||
Mary Jane Johnson | ||||||
President and Chief Executive Officer | ||||||
(Principal Executive Officer) | ||||||
By | /s/ Robert J. Landis | |||||
Robert J. Landis | ||||||
Chairman, Chief Financial Officer and Treasurer | ||||||
(Principal Financial and Accounting Officer) |
22